TME

Advertisement
Oct 18 2024FINANCE

Microsoft's Untapped Potential: A Turnaround Story

JR Research, a top analyst in the tech and software sectors, sees Microsoft as a promising investment opportunity. He focuses on finding growth stocks with strong potential and bargain prices. Microsoft, once a high-flyer, has taken a hit recently. But JR Research believes this could be a chance to

reading time less than a minute
Oct 18 2024BUSINESS

Microsoft's Upcoming Earnings: Expect the Unexpected

Ever wondered how the tech giant Microsoft is doing? Well, the latest buzz is all about their quarterly earnings report coming up soon. Experts like Daniel Sereda, who works for a family office investing across continents, are busy sifting through mountains of data to get a clear picture. Why shoul

reading time less than a minute
Oct 18 2024FINANCE

Microsoft: Time to Explore New Options

Have you ever heard the phrase, "Don't put all your eggs in one basket"? Well, that's exactly what some investors are starting to think about Microsoft (MSFT). Back in April 2024, when the stock was dropping from its high of $429. 37, some experts suggested that Microsoft might face some bumps in th

reading time less than a minute
Oct 18 2024HEALTH

New Ways to Prevent HIV: Injectables vs. Pills

HIV prevention has come a long way. Safe sex practices, like using condoms and reducing partners, are still key. Surgical methods, like male circumcision, can also help. Treating infections is another preventive measure. But, people don't always use these methods. That's why scientists are exploring

reading time less than a minute
Oct 18 2024FINANCE

BlackRock's Big Move: Should You Invest?

Meet BlackRock, a giant in the financial world that's been making waves. The company, which manages over $11 trillion in assets, just crushed expectations with its latest quarterly earnings. CEO Larry Fink shared that the firm added a massive $2 trillion organically over the past five years, making

reading time less than a minute
Oct 18 2024BUSINESS

Biotech Moves: Layoffs, Deals, and Drug Concerns

Let's take a look at what's been happening in the biotech world today. Sage Therapeutics is cutting its workforce by a third and changing its leadership. Why? Recent clinical trial failures have likely played a role. Over in Australia, regulators have rejected Eisai and Biogen's Alzheimer's drug, L

reading time less than a minute
Oct 18 2024CRIME

Twists and Turns: An Olympic Snowboarder's Surprising Path

Once upon a time, Ryan Wedding was a snowboarder representing Canada at the 2002 Winter Olympics. His career may not have reached the podium, but it seems his life took an unexpected turn. Federal prosecutors have revealed that Wedding, now 43, became a major player in the drug trafficking world, al

reading time less than a minute
Oct 18 2024CRIME

School Shooting: Father and Son Facing Charges

On Thursday, a grand jury in Winder, Georgia, indicted a father and son on murder charges. The son, a 14-year-old named Colt Gray, was charged with 55 counts, including murder and assault. His father, Colin Gray, faced 29 counts, including second-degree murder and involuntary manslaughter. The charg

reading time less than a minute
Oct 18 2024BUSINESS

The New Face of Energy: Amazon Picks Nuclear

Amazon Web Services (AWS), the leading cloud computing provider, plans to invest $500 million in nuclear energy projects. This move follows similar announcements by Google and Microsoft. AWS is partnering with Virginia's Dominion Energy to develop small modular nuclear reactors (SMRs). Nuclear energ

reading time less than a minute
Oct 16 2024ENTERTAINMENT

What's Up with That Breathalyzer from Shark Tank Season 5?

You know how Shark Tank has been on ABC since 2009, right? With its celebrity investors and hopeful entrepreneurs, it's a show that keeps viewers guessing. But in Season 5, something astonishing happened. Charles Michael Yim, the founder of Breathometer, pitched his breathalyzer device. This gadget

reading time less than a minute